Cargando…

The Amino Acid Substitution Q65H in the 2C Protein of Swine Vesicular Disease Virus Confers Resistance to Golgi Disrupting Drugs

Swine vesicular disease virus (SVDV) is a porcine pathogen and a member of the species Enterovirus B within the Picornaviridae family. Brefeldin A (BFA) is an inhibitor of guanine nucleotide exchange factors of Arf proteins that induces Golgi complex disassembly and alters the cellular secretory pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Vázquez-Calvo, Ángela, Caridi, Flavia, González-Magaldi, Mónica, Saiz, Juan-Carlos, Sobrino, Francisco, Martín-Acebes, Miguel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4846857/
https://www.ncbi.nlm.nih.gov/pubmed/27199941
http://dx.doi.org/10.3389/fmicb.2016.00612
_version_ 1782429116106014720
author Vázquez-Calvo, Ángela
Caridi, Flavia
González-Magaldi, Mónica
Saiz, Juan-Carlos
Sobrino, Francisco
Martín-Acebes, Miguel A.
author_facet Vázquez-Calvo, Ángela
Caridi, Flavia
González-Magaldi, Mónica
Saiz, Juan-Carlos
Sobrino, Francisco
Martín-Acebes, Miguel A.
author_sort Vázquez-Calvo, Ángela
collection PubMed
description Swine vesicular disease virus (SVDV) is a porcine pathogen and a member of the species Enterovirus B within the Picornaviridae family. Brefeldin A (BFA) is an inhibitor of guanine nucleotide exchange factors of Arf proteins that induces Golgi complex disassembly and alters the cellular secretory pathway. Since BFA has been shown to inhibit the RNA replication of different enteroviruses, including SVDV, we have analyzed the effect of BFA and of golgicide A (GCA), another Golgi disrupting drug, on SVDV multiplication. BFA and GCA similarly inhibited SVDV production. To investigate the molecular basis of the antiviral effect of BFA, SVDV mutants with increased resistance to BFA were isolated. A single amino acid substitution, Q65H, in the non-structural protein 2C was found to be responsible for increased resistance to BFA. These results provide new insight into the relationship of enteroviruses with the components of the secretory pathway and on the role of SVDV 2C protein in this process.
format Online
Article
Text
id pubmed-4846857
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-48468572016-05-19 The Amino Acid Substitution Q65H in the 2C Protein of Swine Vesicular Disease Virus Confers Resistance to Golgi Disrupting Drugs Vázquez-Calvo, Ángela Caridi, Flavia González-Magaldi, Mónica Saiz, Juan-Carlos Sobrino, Francisco Martín-Acebes, Miguel A. Front Microbiol Microbiology Swine vesicular disease virus (SVDV) is a porcine pathogen and a member of the species Enterovirus B within the Picornaviridae family. Brefeldin A (BFA) is an inhibitor of guanine nucleotide exchange factors of Arf proteins that induces Golgi complex disassembly and alters the cellular secretory pathway. Since BFA has been shown to inhibit the RNA replication of different enteroviruses, including SVDV, we have analyzed the effect of BFA and of golgicide A (GCA), another Golgi disrupting drug, on SVDV multiplication. BFA and GCA similarly inhibited SVDV production. To investigate the molecular basis of the antiviral effect of BFA, SVDV mutants with increased resistance to BFA were isolated. A single amino acid substitution, Q65H, in the non-structural protein 2C was found to be responsible for increased resistance to BFA. These results provide new insight into the relationship of enteroviruses with the components of the secretory pathway and on the role of SVDV 2C protein in this process. Frontiers Media S.A. 2016-04-27 /pmc/articles/PMC4846857/ /pubmed/27199941 http://dx.doi.org/10.3389/fmicb.2016.00612 Text en Copyright © 2016 Vázquez-Calvo, Caridi, González-Magaldi, Saiz, Sobrino and Martín-Acebes. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Vázquez-Calvo, Ángela
Caridi, Flavia
González-Magaldi, Mónica
Saiz, Juan-Carlos
Sobrino, Francisco
Martín-Acebes, Miguel A.
The Amino Acid Substitution Q65H in the 2C Protein of Swine Vesicular Disease Virus Confers Resistance to Golgi Disrupting Drugs
title The Amino Acid Substitution Q65H in the 2C Protein of Swine Vesicular Disease Virus Confers Resistance to Golgi Disrupting Drugs
title_full The Amino Acid Substitution Q65H in the 2C Protein of Swine Vesicular Disease Virus Confers Resistance to Golgi Disrupting Drugs
title_fullStr The Amino Acid Substitution Q65H in the 2C Protein of Swine Vesicular Disease Virus Confers Resistance to Golgi Disrupting Drugs
title_full_unstemmed The Amino Acid Substitution Q65H in the 2C Protein of Swine Vesicular Disease Virus Confers Resistance to Golgi Disrupting Drugs
title_short The Amino Acid Substitution Q65H in the 2C Protein of Swine Vesicular Disease Virus Confers Resistance to Golgi Disrupting Drugs
title_sort amino acid substitution q65h in the 2c protein of swine vesicular disease virus confers resistance to golgi disrupting drugs
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4846857/
https://www.ncbi.nlm.nih.gov/pubmed/27199941
http://dx.doi.org/10.3389/fmicb.2016.00612
work_keys_str_mv AT vazquezcalvoangela theaminoacidsubstitutionq65hinthe2cproteinofswinevesiculardiseasevirusconfersresistancetogolgidisruptingdrugs
AT caridiflavia theaminoacidsubstitutionq65hinthe2cproteinofswinevesiculardiseasevirusconfersresistancetogolgidisruptingdrugs
AT gonzalezmagaldimonica theaminoacidsubstitutionq65hinthe2cproteinofswinevesiculardiseasevirusconfersresistancetogolgidisruptingdrugs
AT saizjuancarlos theaminoacidsubstitutionq65hinthe2cproteinofswinevesiculardiseasevirusconfersresistancetogolgidisruptingdrugs
AT sobrinofrancisco theaminoacidsubstitutionq65hinthe2cproteinofswinevesiculardiseasevirusconfersresistancetogolgidisruptingdrugs
AT martinacebesmiguela theaminoacidsubstitutionq65hinthe2cproteinofswinevesiculardiseasevirusconfersresistancetogolgidisruptingdrugs
AT vazquezcalvoangela aminoacidsubstitutionq65hinthe2cproteinofswinevesiculardiseasevirusconfersresistancetogolgidisruptingdrugs
AT caridiflavia aminoacidsubstitutionq65hinthe2cproteinofswinevesiculardiseasevirusconfersresistancetogolgidisruptingdrugs
AT gonzalezmagaldimonica aminoacidsubstitutionq65hinthe2cproteinofswinevesiculardiseasevirusconfersresistancetogolgidisruptingdrugs
AT saizjuancarlos aminoacidsubstitutionq65hinthe2cproteinofswinevesiculardiseasevirusconfersresistancetogolgidisruptingdrugs
AT sobrinofrancisco aminoacidsubstitutionq65hinthe2cproteinofswinevesiculardiseasevirusconfersresistancetogolgidisruptingdrugs
AT martinacebesmiguela aminoacidsubstitutionq65hinthe2cproteinofswinevesiculardiseasevirusconfersresistancetogolgidisruptingdrugs